CAVE CREEK, AZ -- (Marketwired) -- 07/14/14 -- Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today that it has established an attorney-client relationship with Vicente Sederberg LLC., in Denver, Colorado. Endexx has engaged their services because of the thorough knowledge and expertise for all legal and regulatory aspects of the cannabis industry. Brian Vicente, partner and founder, served as the co-director of the Amendment 64 campaign and was one of the primary authors of the measure, resulting in Colorado becoming the first state in the nation to make the possession, use and regulated distribution of marijuana legal for adults.
Todd Davis, CEO Endexx stated, "While we advance M3Hub and our secure dispensing technologies as the standardized compliance platform for the cannabis industry, we seek to collaborate with key legal, political and industry experts that support and are establishing the regulatory and compliance standards for a sustainable industry. Vicente Sederberg and their team of professionals exemplify these standards. Endexx is honored to move our initiative forward with support of this team."
About Vicente Sederberg LLC
Vicente Sederberg LLC, founded in 2010 and with offices in Denver and Massachusetts, is a full service marijuana law firm dedicated to helping clients navigate medical and adult-use marijuana laws around the United States. Vicente Sederberg provides personalized, affordable, and community-focused services for all segments of the marijuana community. The firm has helped hundreds of clients successfully obtain medical marijuana business licenses. In March 2014, the firm placed ninth on 5280 Magazine's list of the "Most Powerful People in Denver." More information about the firm can be found by visiting www.TheMarijuanaLawFirm.com
A persistent, national movement, developing over several decades, has generated an unstoppable momentum shift towards public acceptance and adoption of cannabis as both a viable therapeutic treatment and a responsible adult choice consumer product. This movement has unlocked a multi-billion dollar, sustainable industry with international appeal. As with all lucrative industries, government oversight becomes inevitable and the cost of making money rises. Investing in compliance and industry standards will build the foundation for a worldwide growth industry for the next several decades. Embrace the responsibility and opportunity provided.
Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched in the first half of 2014 -- the m3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com, www.autospense.com
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.